BioCentury
ARTICLE | Company News

Valeant Pharmaceuticals, PreCision Dermatology deal

July 21, 2014 7:00 AM UTC

Valeant completed its acquisition of dermatology company PreCision for $475 million in cash, plus up to an additional $25 million in sales-based milestones (see BioCentury, Feb. 10). ...